Emergence of new psychoactive substance 2-fluorodeschloroketamine: Toxicology and urinary analysis in a cluster of patients exposed to ketamine and multiple analogues

2020 ◽  
Vol 312 ◽  
pp. 110327 ◽  
Author(s):  
Magdalene H.Y. Tang ◽  
Terence C. Li ◽  
C.K. Lai ◽  
Y.K. Chong ◽  
C.K. Ching ◽  
...  
2021 ◽  
Vol 104 (2) ◽  
pp. 252-259

Objective: To explore the associations of characteristics of the cluster environment with new psychoactive substances (NPS) use in Thailand. Materials and Methods: A cross-sectional study was done on 30,411 Thai people, stratified in multi-stage cluster sampling. Trained interviewers conducted a semi-structured interview in 2016. A multilevel binary logistic regression model was employed to estimate the effects of the cluster environment on the NPS use. Results: NPS was widely used. The past month prevalence was 13.6%, and habitual use was 4.4%. Clustering significantly affects the spread of NPS use. Controlling for cluster effects, a likelihood of current NPS use was associated with elementary education, occupation, and reported health problems. While a higher likelihood of habitual NPS use was associated with elementary education, employed, and perceived mental health problem. Conclusion: NPS use was influenced by characteristics of the cluster environment. Therefore, demand reduction strategies should be designed based on a consideration of the impact of cluster context on NPS use behaviors. Keywords: Cluster effect, New psychoactive substance, NPS, Thailand


Author(s):  
Jonathan Melamed ◽  
Roy Gerona ◽  
Paul D Blanc ◽  
Paul Takamoto ◽  
Stephanie Conner ◽  
...  

Abstract Gamma-hydroxybutyrate (GHB) is misused as an intoxicant, either alone or concurrently with other substances. Because GHB is illegal, the precursor chemicals 1,4-butanediol and gamma-butyrolactone are also misused for the same effect, either through pre-ingestion alteration or endogenous metabolism to GHB. We describe a case of a 50-year-old man with a history of polysubstance misuse who experienced an overdose of GHB from gamma-butyrolactone ingestion. The patient also co-ingested a common industrial solvent, N-methyl-2-pyrrolidone (NMP). This co-ingested substance raised theoretical concern of metabolism to a GHB congener, underscoring that the emergence of new psychoactive substance use patterns requires ongoing vigilance and toxicologic confirmation.


2020 ◽  
Vol 731 ◽  
pp. 139209 ◽  
Author(s):  
Richard Bade ◽  
Jason M. White ◽  
Lynn Nguyen ◽  
Benjamin J. Tscharke ◽  
Jochen F. Mueller ◽  
...  

2016 ◽  
Vol 9 (3) ◽  
pp. 415-422 ◽  
Author(s):  
Torben Breindahl ◽  
Andreas Kimergård ◽  
Mette Findal Andreasen ◽  
Daniel Sejer Pedersen

Author(s):  
Arnis Slesars ◽  
Aija Jermacāne

A new psychoactive substance is defined as a new narcotic or psychotropic drug, in pure form or in preparation, that is not controlled by the United Nations drug conventions (1961, 1971), but which may pose a public health threat comparable to that posed by substances listed in these conventions. The author researched and analyzed: 1.History of new psychoactive substances in Latvia; 2.Legislative approaches for restricting new psychoactive substances in Latvia; 3.Advantages and disadvantages of criminal liability against new psychoactive substances in Latvia.


2017 ◽  
Vol 43 ◽  
pp. 23-32 ◽  
Author(s):  
Rachel Sutherland ◽  
Raimondo Bruno ◽  
Amy Peacock ◽  
Simon Lenton ◽  
Allison Matthews ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document